Kirt Gill

Kirt Gill, MD is currently the CEO and Co-Founder of NeuraStasis, a company developing novel devices for patients with acute ischemic stroke. Prior to this, Kirt also served as a Clinical Advisor and Business Dev and R+D Specialist at Solenic Medical, an early stage medical device company. Additionally, Kirt has been involved in various roles at different companies, including being a Cohort Member at ZeroTo510 - Medical Device Accelerator and a Biodesign Fellow at Texas Medical Center. Kirt's educational background includes a BA in Molecular Biology and Classical Civilizations from the University of California, Berkeley, and a Doctor of Medicine (MD) from Keck School of Medicine of the University of Southern California.